DEA opens comment period on proposed Schedule I placement
DEA proposed rule to place tianeptine and related forms in Schedule I, Docket No. DEA1596. Who can act: Drug Enforcement Administration, Department of Justice.
A decision is open
/Regulatory Comment
DEA proposed rule to place tianeptine and related forms in Schedule I, Docket No. DEA1596
Drug Enforcement Administration, Department of Justice
↓ Congress can act on this
This story is connected to S3677: Dietary Supplement Listing Act of 2026 — legislation your representatives can act on.
S3677 · 119th Congress
Dietary Supplement Listing Act of 2026
Where do you stand on this bill?
Takes about 60 seconds
About this bill
What S3677 actually does
This story is about Research lead: DEA opens comment period on proposed Schedule I placement. This bill would not schedule tianeptine, but it squarely addresses the information gap that lets dangerous products circulate as supplements